We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

81 hedge funds and large institutions have $17.5M invested in Ampio Pharmaceuticals Inc. in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

243% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 7

143% more call options, than puts

Call options by funds: $784K | Put options by funds: $323K

56% more capital invested

Capital invested by funds: $11.2M → $17.5M (+$6.25M)

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

3% more funds holding

Funds holding: 79 → 81 (+2)

Holders
81
Holders Change
+2
Holders Change %
+2.53%
% of All Funds
1.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
7
Closed
14
Calls
$784K
Puts
$323K
Net Calls
+$461K
Net Calls Change
+$176K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$542K
2
First Trust Advisors
First Trust Advisors
Illinois
+$339K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$150K
4
BJL
Brighton Jones LLC
Washington
+$123K
5
WWM
Western Wealth Management
Colorado
+$104K

Top Sellers

Rank Fund Capital Flow
1
PCMC
Private Capital Management (Colorado)
Colorado
-$771K
2
BlackRock
BlackRock
New York
-$65.7K
3
TFS
TrustCore Financial Services
Tennessee
-$49.1K
4
MMA
Miracle Mile Advisors
California
-$25K
5
WS
Wedbush Securities
California
-$21.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAGAS
76
Capital Advisory Group Advisory Services
Minnesota
$1K – – –
UBS Group
77
UBS Group
Switzerland
$1K – – –
GEA
78
Glen Eagle Advisors
New Jersey
$957 – – –
FCH
79
Freestone Capital Holdings
Washington
$957 +$744 +3 New
Millennium Management
80
Millennium Management
New York
$10 +$8.43K +34 New
PCMC
81
Private Capital Management (Colorado)
Colorado
– -$771K -4,033 Closed
MMA
82
Miracle Mile Advisors
California
– -$25K -133 Closed
PNC Financial Services Group
83
PNC Financial Services Group
Pennsylvania
– -$9K -46 Closed
CHA
84
Cooper/Haims Advisors
New York
– -$8K -43 Closed
OC
85
Oppenheimer & Co
New York
– -$6K -34 Closed
CAL
86
Capital Analysts LLC
Pennsylvania
– -$6K -33 Closed
SCA
87
Stonebridge Capital Advisors
Minnesota
– -$3K -17 Closed
TRCT
88
Tower Research Capital (TRC)
New York
– -$3K -14 Closed
AWM
89
Apollon Wealth Management
South Carolina
– -$2K -11 Closed
CCM
90
Covington Capital Management
California
– -$2K -11 Closed
CAN
91
Cetera Advisor Networks
California
– -$2K -8 Closed
CFG
92
Citizens Financial Group
Rhode Island
– -$1K -6 Closed
BNP Paribas Financial Markets
93
BNP Paribas Financial Markets
France
– -$104 -1 Closed
1 2 3
4

AMPE Hedge Fund Activity: Q3 2020 in Review

81 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2020, worth a combined $17.5M — up 56% from $11.2M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new AMPE positions and 14 closed out — a net gain of 2 holders — while 24 added to existing stakes and 7 trimmed.

The largest buyer was Vanguard Group, adding an estimated $542K. The largest seller was Private Capital Management (Colorado), exiting entirely with an estimated $771K sold.

  • 81 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2020, up from 79 in Q2 2020.
  • Funds reported $17.5M of Ampio Pharmaceuticals Inc. stock for Q3 2020, up 56% quarter-over-quarter.
  • 16 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2020 and 14 closed out, a net change of +2 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2020 was Vanguard Group, an estimated $542K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2020 was Private Capital Management (Colorado), an estimated $771K sold.

Based on aggregated 13F filings for Q3 2020.